On Friday, Shares of Abbott Laboratories (NYSE:ABT), SUBTRACT -0.46% and closed at $40.79 in the last trading session. The last trading range of the stock ranges between $40.77 and $41.53. Khang & Khang LLP (the “Firm”) declares that it is investigating claims against Abbott Laboratories (“Abbott” or the “Company”) (ABT) concerning possible violations of federal securities laws.
On April 28, 2016, Abbott declared a definitive agreement to acquire St. Jude Medical Inc. (“St. Jude”). On October 11, 2016, St. Jude issued a warning to physicians and patients that batteries on thousands of its implantable defibrillators can quickly and unexpectedly deplete. Two people died after their devices failed to work correctly because of the drained battery, while 47 others stated dizziness or fainting. The warning applied to devices made before May 2015, which are in use by about 350,000 people worldwide. Abbott stated that it still anticipates to close its acquisition of St. Jude by the end of 2016.
Activision Blizzard, Inc. (NASDAQ:ATVI), jumped 1.23% and closed at $43.69 in the last trading session. The last trading range of the stock ranges between $43.41 and $44.33. The company’s Market capitalization is $32.79 Billion with the total Outstanding Shares of 741.47 Million. The start of the highly anticipated Call of Duty®: Infinite Warfare multiplayer beta kicks off recently on PlayStation®4 computer entertainment system. Gamers who pre-ordered the game on PS4™ system will obtain a beta access code for instant access to the Call of Duty: Infinite Warfare multiplayer beta. They will experience Infinite Warfare multiplayer firsthand, counting all-new maps, the all-new Combat Rigs system, new weaponry, unique progression systems, mission teams, select multiplayer modes and more, starting now through 10:00 a.m. PT, Monday, Oct. 17.
“Infinite Warfare multiplayer is about customizing the experience to fit different play styles, and that begins with Rigs,” said Dave Stohl, Studio Head of Infinity Ward. “In the Beta, players will get their hands on our new Rigs, abilities, equipment, and of course our new craftable, prototype weapons. With new maps and modes, there’s a ton of cool new stuff here, and we’re excited to share a slice of multiplayer with the community. The data we’ll receive over these next two weekends will be assistful as we get ready to share the full multiplayer experience next month at release.”
Mast Therapeutics Inc (NYSEMKT:MSTX), LOST -7.19and closed at $0.0800 in the last trading session. The last trading range of the stock ranges between $0.08 and $0.09. The company’s Market capitalization is $15.73 Million with the total Outstanding Shares of 211.82 Million. During the 52-week trading session the minimum price at which share price traded, registered at $0.08 and reached to max level of $0.71. Mast Therapeutics, Inc. (NYSE MKT: MSTX), recently declared that the Company’s Chief Executive Officer, Brian M. Culley, will provide an update related to its business strategy and clinical development of its product candidates at the 2016 BIO Shareholder Forum on Wednesday, October 19, 2016 at 2:30 p.m. Pacific time in the Elizabethan B Salon at the Westin St. Francis hotel in San Francisco. The Company recently declared a planned focus on its AIR001 (sodium nitrite solution for intermittent inhalation) program with continued support for multiple investigator-sponsored Phase 2 clinical studies of AIR001 being conducted at prestigious research institutions, with interim results from one of these studies anticipated to be published this quarter.